[Unanswered questions in the management of cervical cancer].
The Task Force Group "Uterus of the Association of Gynecologic Oncology" has recently published the interdisciplinary S2 guidelines on diagnostics and therapy of cervical cancer. In view of quality development strategies of the German Cancer Society and the German Society for Obstetrics and Gynecology, a practicable concept with clear algorithms for gynecologists has been presented. Nevertheless, both development of oncologic sciences and daily practice, lead to new questions which should be answered by prospective studies. In this respect, women with cervical cancer should be treated on the same level of quality as patients with breast cancer. As discussed both nationally and internationally, laparoscopic staging, the development of laparoscopic surgical techniques (i. e., laparoscopic-assisted radical vaginal hysterectomy), the safety and efficacy of the sentinel concept, and TMMR, and finally, the indication for trachelectomy are main scientific questions. Also, innovative vaccination studies that might increase hope of a breakthrough even in cervical cancer prevention, the implementation of nerve-sparing surgical techniques, the radical parametrectomy or current strategies on exenteration are main focuses of clinical gynecologic oncology.
Ebert
A D
AD
Klinik für Gynäkologie und Geburtsmedizin, Vivantes Humboldt-Klinikum, Berlin. andreas.ebert@vivantes.de
Ulrich
U
U
Beckmann
M W
MW
Schneider
A
A
D002584:Cervix Uteri / Q000473:pathology; D005260:Female; D005858:Germany; D006801:Humans; D007045:Hysterectomy, Vaginal; D010535:Laparoscopy; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011446:Prospective Studies; D011785:Quality Assurance, Health Care; D021701:Sentinel Lymph Node Biopsy; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000601:surgery*